Clinical trial
The Role of TAB3 Protein in Tumorigenesis
NCT00899132 is registered in ClinicalTrials.gov with Case Comprehensive Cancer Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Role of TAB3 Protein in Tumorigenesis
- Lead sponsor
- Case Comprehensive Cancer Center
- Phase
- Observational
- Overall status
- Terminated
- Start date
- February 28, 2007
- Completion date
- September 30, 2012
- Enrollment
- 180 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
non-melanomatous skin cancer, pancreatic cancer, small intestine cancer, testicular germ cell tumor